Richard Curry

Company: Bexion

Job title: Medical Affairs Advisor

Seminars:

Leveraging the Lysosome to Treat Glioblastoma 2:40 pm

BXQ-350 – a unique, first in class, lysosomal protein (in lipid nanovesicle) involved in cellular homeostasis Phase 1 clinical trial findings of extraordinary safety and tolerability with monotherapy effect Planned clinical trials in newly diagnosed GBM – combination therapy with radiation and temozolomideRead more

day: Day Two